This trial is active, not recruiting.

Conditions atopic dermatitis, food hypersensitivity, allergic rhinitis, seasonal, allergic conjunctivitis, asthma
Treatment mixture of probiotic bacteria and prebiotic oligosaccharide
Phase phase 2/phase 3
Sponsor Helsinki University
Start date October 1999
End date December 2007
Trial identifier NCT00298337, T101060058;T1040A0002;T110612


The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double-blind
Primary purpose prevention

Eligibility Criteria

Male or female participants from 37 weeks up to 42 weeks old.

Inclusion Criteria: - mother or father fo child with doctor diagnoses allergic disease Exclusion Criteria: - prematurity, major malformations

Trial information was received from ClinicalTrials.gov and was last updated in October 2006.
Information provided to ClinicalTrials.gov by Helsinki University.